B and T cell immunity in patients with lysinuric protein intolerance

Clinical and Experimental Immunology

Volumn 116, Issue 3, 1999, Pages 430-434

  Lukkarinen, Mari ^a   Parto, K ^a   Ruuskanen, O ^a   Vainio, O ^a   Kayhty H ^b   Olander R M ^b   Simell, O ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

B cell function; Hyperammonaemia; Lysinuric protein intolerance; Transport disorders; Vaccination

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; ANTIBODY TITER; ARTICLE; CELL TRANSPORT; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; DIPHTHERIA; FAILURE TO THRIVE; FEMALE; HAEMOPHILUS INFLUENZAE; HEPATOSPLENOMEGALY; HUMAN; HUMORAL IMMUNITY; IMMUNE SYSTEM; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; INFLUENZA VACCINATION; LYMPHOCYTE FUNCTION; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN INTAKE; PROTEIN INTOLERANCE; PROTEIN TRANSPORT; TETANUS PROPHYLAXIS; UREA CYCLE;

ADULT; AMINO ACID METABOLISM, INBORN ERRORS; AMMONIA; B-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; LYSINE; MALE; MIDDLE AGED; T-LYMPHOCYTES; VACCINATION;

EID: 0033030431     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00868.x     Document Type: Article

References (33)

1. Smith DW, Scriver CR, Tenenhouse HS, Simell O. Lysinuric protein intolerance mutation is expressed in the plasma membrane of cultured skin fibroblasts. Proc Natl Acad Sci USA 1987; 84:7711-5.
2. Smith DW, Scriver CR, Simell O. Lysinuric protein intolerance mutation is not expressed in the plasma membrane of erythrocytes. Hum Genet 1988; 80:395-6.
3. Simell O. Lysinuric protein intolerance and other cationic aminoacid urias. In: Scriver C, Beaudet A, Sly W, Valle D, eds. The metabolic basis of inherited disease. New York: McGraw-Hill, 1989:2497-513.
4. Perheentupa J, Simell O. Lysinuric protein intolerance. Birth Defects 1974; 10:201-7.
5. Rajantie J, Simell O, Rapola J, Perheentupa J. Lysinuric protein intolerance: a two-year trial of dietary supplementation therapy with citrulline and lysine. J Pediatr 1980; 97:927-32.
6. Parto K, Svedstrom E, Majurin ML, Harkonen K, Simell O. Pulmonary manifestations in lysinuric protein intolerance. Chest 1993; 104:1176-82.
7. Lukkarinen M, Näntö-Salonen K, Ruuskanen O et al. Varicella and varicella immunity in patients with lysinuric protein intolerance. J Inher Metab Dis 1998; 21:103-11.
8. Nagala M, Suzuki M, Kawamura G et al. Immunological abnormalities in a patient with lysinuric protein intolerance. Eur J Pediatr 1987; 146:427-8.
9. Pardo K, Kallajoki M, Aho H, Simell O. Pulmonary alveolar proteinosis and glomerulonephritis in lysinuric protein intolerance: case reports and autopsy findings of four pediatric patients. Hum Pathol 1994; 25:400-7.
10. Viug A, Nieuwenhuys EJ, van Eyk RVW, Geertzen HGM, van Houte AJ. Nephelometric measurements of human IgG subclasses and their reference ranges. Ann Biol Clin 1994; 52:561.
11. Miyamurat K, Nishio S, Ito A, Murata R, Kono R. Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies of factors affecting the toxin and antitoxin titration. J Biol Stand 1974; 2:189-201.
12. Miyamurat K, Tajiri E, Ito A, Murata R, Kono R. Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. II. Comparison with rabbit skin method and practical application for seroepidemiological studies. J Biol Stand 1974; 2:203-9.
13. Hendriksen CF, van den Gun JW, Nagel J, Kreeftenberg JG. The toxin binding inhibition test as a reliable in vitro alternative to the toxin neutralization test in mice for the estimation of tetanus antitoxin in human sera. J Biol Stand 1988; 16:287-97.
14. Madore DV, Anderson P, Carlone GM et al. Interlaboratory study evaluating quantitation of antibodies Haemophilus influenza type b polysaccharide by ELISA. J Clin Microbiol 1996; 3:84-88.
15. Käyhty H, hman H, Rönnberg P, Tillikainen R, Eskola J. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J Infect Dis 1995; 172:1273-8.
16. Nieminen T, Käyhty H, Virolainen A, Eskola J. Circulating antibody secreting cell response to parental pneumococcal vaccine as an indicator of a salivary IgA antibody response. Vaccine 1997; 16:313-9.
17. Itälä M, Vainio O, Remes K. Functional abnormalities in granulocytes predict susceptibility to bacterial infections in chronic lymphocytic leukaemia. Eur J Haematol 1996; 57:46-53.
18. Reichert T, DeBruyere M, Deneys V et al. Lymphocyte subset reference ranges in adult caucasians. Clin Immunol Immunopathol 1991; 60:190-208.
19. Käyhty H, Eskola J, Peltola H et al. Antibody responses to four Haemophilus influenzae type b conjugate vaccines. Am J Dis Child 1991; 145:223-7.
20. Gennery AR, Cant AJ, Spickett GP. Effect of immunosuppression after cardiac transplantation in early childhood on antibody response to polysaccharide antigen. Lancet 1998; 351:1778-81.
21. Linde A, Söderström R, Smith CIE et al. Herpesvirus serology, aberrant specific immunoglobulin G2 and G3 subclass patterns and Gm allotypes in individuals with low levels of IgG3. Clin Exp Immunol 1992; 90: 199-203.
22. Snowden JA, Milford-Ward A, Cookson LJ, McKendrick MW. Recurrent lymphocytic meningitis associated with isolated IgG subclass 3 deficiency. J Infect Dis 1993; 27:285-9.
23. Keusch GT. Nutritional effects on response of children in developing countries to respiratory tract pathogens: implications for vaccine development. Rev Infect Dis 1991; 13 (Suppl. 6):S486-91.
24. Ozkan H, Olgun N, Sasmaz E, Abacioglu H, Okuyan M, Cevik N. Nutrition, immunity and infections: T lymphocyte subpopulations in protein-energy malnutrition. J Trop Pediatr 1993; 39:257-60.
25. Rajantie J. Orotic aciduria in lysinuric protein intolerance: dependence on the urea cycle intermediates. Pediatr Res 1981; 15:115-9.
26. Zieve L. Conditional deficiencies of ornithine or arginine. J Am Coll Nutr 1986; 5:167-76.
27. Girot R, Durandy A, Perignon JL, Griscelli C. Hereditary orotic aciduria: a defect of pyrimidine metabolism with cellular immunodeficiency. Birth Defects 1983; 19:313-6.
28. Rajantie J, Simell O, Perheentupa J. Intestinal absorption in lysinuric protein intolerance: impaired for diamino acids, normal for citrulline. Gut 1980; 21:519-24.
29. Rajantie J, Simell O, Perheentupa J. Lysinuric protein intolerance. Basolateral transport defect in renal tubuli. J Clin Invest 1981; 67:1078-82.
30. Hallman M, Maasilta P, Sipila I, Tahvanainen J. Composition and function of pulmonary surfactant in adult respiratory distress syndrome. Eur Respir J 1989; 3:S104-8.
31. Christensen HH. A retrovirus uses a cationic amino acid transporter as a cell surface receptor. Nutr Rev 1992; 50:47-48.
32. Rajantie J, Simell O, Perheentupa J. Basolateral-membrane transport defect for lysine in lysinuric protein intolerance. Lancet 1980; 1:1219-21.
33. Report of a WHO Scientific Group. Primary immunodeficiency diseases. Clin Exp Immunol 1995; 99:1-24.